The Angels' Forum

The Angels' Forum LLC is a venture capital firm established in 1997 and based in Redwood City, California, specializing in seed and early-stage investments. The firm focuses on disruptive technologies across various sectors, including software, consumer products, life sciences, and clean technologies. It primarily invests in companies located within 50 miles of Mountain View, California, and typically allocates between $0.1 million and $1 million per investment. The Angels' Forum prefers to invest in companies seeking Series A financing and participates in subsequent funding rounds, such as Series B and C. The firm collaborates with prominent venture funds and corporate partners, emphasizing a selective investment approach without taking a board seat. Annually, it invests in five to ten companies, leveraging its network to support portfolio growth in the competitive Silicon Valley landscape.

Carol Sands

Venture Partner

38 past transactions

VIDA

Series C in 2020
VIDA Diagnostics, Inc. specializes in clinical imaging software and analysis services, focusing on lung and respiratory care. The company's flagship products include LungPrint, an automated AI-powered tool that analyzes chest CT scans to assess lung physiology and functional tissue, and VIDA|precision, which provides detailed lung measurements for pulmonary clinicians. Additionally, VIDA|vision enables interactive examination of advanced quantitative imaging analysis results. The company offers comprehensive image analysis services for both academic and clinical trials, including study design, CT protocol development, and data analysis. Founded in 2004 and headquartered in Coralville, Iowa, with an office in Minneapolis, VIDA's software is FDA cleared and CE-marked, making it suitable for clinical use in multiple regions, including the US, European Economic Area, Canada, and Australia. Through its innovative solutions, VIDA aims to empower healthcare organizations and physicians to enhance patient outcomes, especially for those at risk of chronic respiratory diseases such as COPD, interstitial lung disease, lung cancer, and COVID-19.

OneMob

Venture Round in 2017
OneMob, Inc. is a communications platform based in San Francisco, California, specializing in video engagement solutions for businesses. The company provides a user-friendly platform that enables sales, customer success, and support representatives to create personalized video and voice messages. These messages can be recorded, uploaded, and sent to enhance customer interactions, ultimately driving sales and renewals. OneMob's integration with Salesforce allows users to customize landing pages and track engagement in real-time, making it an effective tool for prospecting and closing deals. Founded in 2014, OneMob has gained recognition in the industry for its ability to facilitate meaningful connections through video, positioning it as a preferred choice for enterprises seeking to enhance their communication strategies.

Halio

Series C in 2017
Kinestral Technologies, Inc. specializes in manufacturing smart-tinting glass, branded as Halio, for both commercial and residential applications. Halio glass can transition from clear to tinted or dark, either automatically or on command, enhancing architectural design by providing versatile solutions for windows, walls, and skylights. This technology offers significant advantages over traditional electrochromic glass, including faster tinting, uniform coloration, and a natural appearance. Kinestral also provides a range of supporting products, such as the Halio Tint Selector, which allows localized control of window tinting, and Halio Cloud, an interface for integrating window operations with building automation systems. Founded in 2010 and headquartered in Hayward, California, Kinestral has established a strategic partnership with Asahi Glass Co., Ltd. Its advanced manufacturing techniques ensure reliable production and timely delivery for projects worldwide, ultimately aiming to improve energy efficiency and comfort in indoor environments.

Kiana Analytics

Series A in 2017
Kiana Analytics Their founding team's experience in Big Data analytics has driven Their technology goals towards providing an entirely new depth of customer understanding through Presence Analytics. Kiana can help retailers increase store performance and sales conversion by matching web-based vendor capabilities to analyze customer traffic before the Point of Sale.

Glue Networks

Venture Round in 2017
Glue Networks specializes in providing an enterprise-grade cloud networking service. Glue Virtual Office is available to enterprise customers through partnerships between Glue Networks and top service providers and value-added resellers. It was founded in 2007 and headquartered in Sacramento, California.

Hospi

Venture Round in 2017
Hospi Corporation specializes in developing and manufacturing medical devices aimed at improving the quality of life for patients with serious or terminal illnesses, as well as assisting their caregivers. The company is best known for the Macy Catheter, a patented device designed to facilitate discreet rectal administration of liquids and medications, which is especially beneficial for patients who have difficulty swallowing. This innovative catheter, co-developed by a hospice nurse, addresses an important need in hospice and palliative care settings. Hospi also offers The Liquipill system for preparing medication suspensions from pills, a bedside care kit for using the Macy Catheter, and a valved port for urinary catheter irrigation. Founded in 2012, the company is based in Newark, California, and focuses on enhancing patient comfort and caregiver efficiency while reducing costs in healthcare delivery.

Chimera Bioengineering

Venture Round in 2016
They aspire to control the immune system. By the time a patient is sitting in front of an oncologist, cancer has evaded their immune system. Chimeric antigen receptor T-cells (CARs) are reprogrammed immune cells, hot-wired to circumvent immune-evasion. Clinical trials for CARs against liquid tumor cancers, like acute lymphoblastic leukemia and lymphoma, have shown transformative results for patients unresponsive to standard therapy. However, limited efficacy against solid tumor cancers, life-threatening toxicities, and limited persistence are impediments to these therapies making a wider impact on cancer patients. Chimera Bioengineering solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program the "software" of the immune system. They design CAR behavior that promises to minimize toxicity, maximize efficacy and extend persistence so that CARs can lead to cures.w

Sonoma Orthopedics

Venture Round in 2016
Sonoma Orthopedic Products specializes in the design, development, and delivery of proprietary orthopedic implants aimed at assisting physicians in the treatment of problematic fractures. The company's innovative WaviBody technology platform facilitates quick and minimally invasive surgical solutions, catering to the needs of active patients. By focusing on advanced orthopedic solutions, Sonoma Orthopedic Products aims to enhance patient recovery and overall quality of care.

Glue Networks

Venture Round in 2016
Glue Networks specializes in providing an enterprise-grade cloud networking service. Glue Virtual Office is available to enterprise customers through partnerships between Glue Networks and top service providers and value-added resellers. It was founded in 2007 and headquartered in Sacramento, California.

The Detection Group

Venture Round in 2016
The Detection Group, Inc. is a technology company specializing in monitoring and alarming solutions designed to mitigate the risks and damages associated with water leaks in various properties, including commercial, residential, retail, and medical facilities across the United States. Founded in 2006, the company has developed a web-based automatic leak detection and 24/7 monitoring system that continuously observes potential water sources. In the event of a leak, the system triggers local alarms, alerts designated personnel, and can shut off the water supply if necessary. Additionally, it tracks response times to leaks, providing valuable information for insurance purposes. The Detection Group serves a diverse clientele, including commercial property managers, residential property managers, and insurance providers, and distributes its detection systems through dealers located in several states, including Maryland, New Jersey, New York, California, and Massachusetts. The company's headquarters is situated in Mountain View, California, with a satellite office in San Diego.

Ittavi

Venture Round in 2016
Ittavi, Inc. was the original creator of SupportPay, a payment platform designed to assist single, divorced, separated, and blended families in managing their financial relationships. The platform enabled parents to handle child support and shared expenses, facilitating direct communication and transactions between them. Users could track expenses, store receipts, dispute items, and process payments through the application. However, Ittavi, Inc. was liquidated in early 2018, and its assets, including SupportPay, were acquired by Smart Family Tech, Inc., which now operates the platform.

RenovoRx

Series C in 2015
RenovoRx, Inc. is a medical device company based in Los Altos, California, focused on developing innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites in the peripheral vascular system. Founded in 2012, the company has created the RenovoCath, an endovascular catheter designed for use in the visceral and peripheral vascular systems. RenovoRx has received FDA clearance for its RenovoCath RC120 and is actively introducing this technology to the clinical market. The company aims to enhance treatment outcomes for cancer patients through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which strategically targets tumors while potentially reducing the side effects associated with traditional systemic therapies. Supported by a knowledgeable Board of Directors and an Advisory Board comprising interventional radiologists, surgical oncologists, and gastroenterologists, RenovoRx is committed to advancing its clinical development strategies and addressing significant unmet medical needs.

DecisionNext

Seed Round in 2015
DecisionNext, Inc. offers a cloud-based predictive analytics platform tailored for commodities-driven businesses, providing industry-specific insights that assist users in making informed decisions about production and sales locations. The company serves a diverse clientele across sectors such as minerals, agribusiness, fishing, forestry, oil, and gas. Established in 2013 and headquartered in San Francisco, California, with an additional office in Brisbane, Australia, DecisionNext focuses on enhancing end-to-end performance through its solutions, which include commodity price forecasting, purchasing and product mix optimization, capacity optimization, and pricing and promotion strategies. By integrating these optimizations into a cohesive system, DecisionNext aims to deliver significant value to its customers.

Zephyrus Biosciences

Seed Round in 2014
Zephyrus Biosciences, Inc. is a life science research tools company based in Berkeley, California, founded in 2013. The company specializes in the development and commercialization of innovative research tools that facilitate protein analysis at the single-cell level. Its flagship product, the scWestern System, allows for western blotting on individual cells, a significant advancement in the field of single-cell analysis. This system employs microfluidics technology to isolate single cells in micro-wells, lysing them and performing SDS-PAGE separation on each lysate. Researchers utilize Zephyrus's tools to explore critical areas such as cancer biology, stem cell research, neurology, and broader human disease studies, ultimately contributing to advancements in diagnostics and therapeutics. As of March 2016, Zephyrus operates as a subsidiary of Bio-Techne Corp.

Gemmus Pharma

Series B in 2014
Gemmus Pharma Inc. is a biotechnology company based in San Francisco, California, founded in 2007. The company focuses on developing therapeutics for the treatment of influenza and other infectious diseases. Its lead candidates include GP1001, a non-peptidic eicosanoid analog designed for serious influenza infections that may require hospitalization, and GP1681, which aims to alleviate influenza symptoms by reducing the exaggerated cytokine response induced by the virus. GP1001 can be used as a stand-alone treatment or in combination with antiviral drugs such as oseltamivir. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Disease and has plans to file an investigational new drug application with the FDA to advance its influenza treatment initiatives.

RenovoRx

Series B in 2014
RenovoRx, Inc. is a medical device company based in Los Altos, California, focused on developing innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites in the peripheral vascular system. Founded in 2012, the company has created the RenovoCath, an endovascular catheter designed for use in the visceral and peripheral vascular systems. RenovoRx has received FDA clearance for its RenovoCath RC120 and is actively introducing this technology to the clinical market. The company aims to enhance treatment outcomes for cancer patients through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which strategically targets tumors while potentially reducing the side effects associated with traditional systemic therapies. Supported by a knowledgeable Board of Directors and an Advisory Board comprising interventional radiologists, surgical oncologists, and gastroenterologists, RenovoRx is committed to advancing its clinical development strategies and addressing significant unmet medical needs.

Intrapace

Venture Round in 2012
IntraPace, Inc. specializes in the development and marketing of implantable devices aimed at treating obesity. Founded in 2001 and located in Mountain View, California, the company has created the abiliti system, which stimulates a satiety response to facilitate weight loss. This innovative device is based on technology commonly used in cardiac pacemakers and defibrillators, allowing for implantation through standard laparoscopic methods. Notably, the abiliti system does not alter the digestive system's anatomy and imposes no restrictions on a patient's dietary intake, making it a versatile option for individuals seeking weight management solutions.

Gemmus Pharma

Series A in 2012
Gemmus Pharma Inc. is a biotechnology company based in San Francisco, California, founded in 2007. The company focuses on developing therapeutics for the treatment of influenza and other infectious diseases. Its lead candidates include GP1001, a non-peptidic eicosanoid analog designed for serious influenza infections that may require hospitalization, and GP1681, which aims to alleviate influenza symptoms by reducing the exaggerated cytokine response induced by the virus. GP1001 can be used as a stand-alone treatment or in combination with antiviral drugs such as oseltamivir. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Disease and has plans to file an investigational new drug application with the FDA to advance its influenza treatment initiatives.

Turpitude

Series A in 2011
Turpitude provides clients, including developers, publishers and property holders, with AAA game design consulting services along with creating games as well.

Qumu

Debt Financing in 2010
Qumu Corporation specializes in providing comprehensive tools for the creation, management, security, distribution, and delivery of live and on-demand video content tailored for enterprises. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services to enhance user experience. Its offerings cater to various sectors, including banking, finance, insurance, manufacturing, technology, healthcare, and government, through both direct sales and partnerships. Established in 1978 and headquartered in Minneapolis, Minnesota, Qumu was previously known as Rimage Corporation before rebranding in 2013.

Bella Pictures

Debt Financing in 2009
Bella Pictures, Inc. provides an innovative approach to wedding photography and offers affordable, world-class photography for weddings. Bella Pictures' services include photography and videography packages for weddings, expert advice, a variety of album options, and other add-on services. Bella Pictures, Inc. was founded in 2003 and is headquartered in San Francisco, California.

Qumu

Series C in 2008
Qumu Corporation specializes in providing comprehensive tools for the creation, management, security, distribution, and delivery of live and on-demand video content tailored for enterprises. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services to enhance user experience. Its offerings cater to various sectors, including banking, finance, insurance, manufacturing, technology, healthcare, and government, through both direct sales and partnerships. Established in 1978 and headquartered in Minneapolis, Minnesota, Qumu was previously known as Rimage Corporation before rebranding in 2013.

MOG

Series C in 2008
MOG Inc. is a music media company founded in June 2005, focused on enhancing the music listening experience through its on-demand streaming service. The platform offers access to a vast library of over 14 million songs and one million albums, available across multiple devices including mobile apps for iPhone and Android, web browsers, and various streaming devices. MOG's user-friendly interface, exceptional discovery features, and high audio quality set it apart from competitors. Additionally, MOG operates The MOG Music Network, which is a prominent online destination for music content and the largest music-focused advertising network, attracting over 60 million unique visitors each month across more than 1,500 music websites. Headquartered in Berkeley, California, MOG has received investment from notable firms, including Menlo Ventures and Universal Music Group, and features Grammy-winning producer Rick Rubin on its Board of Directors.

Podaddies

Angel Round in 2007
Podaddies, Inc. is an online video advertising company based in San Francisco, California, specializing in in-stream video advertising technology. Founded in 2006, Podaddies enables marketers to integrate media content into video formats, even post-download, while offering a platform for tracking, targeting, and managing advertising campaigns. Their proprietary technology allows advertisers to insert video ads into content in real time and provides viewer, contextual, and behavioral targeting services. Podaddies serves a diverse clientele that includes content publishers, social networks, podcasters, and video consumers. The company is recognized for its innovative and flexible advertising solutions that help marketers reach targeted audiences effectively across various platforms, including mobile and online video. As a privately-held corporation, Podaddies is supported by experienced investors and continues to enhance its services and technologies to meet the evolving needs of the advertising landscape.

MOG

Series B in 2007
MOG Inc. is a music media company founded in June 2005, focused on enhancing the music listening experience through its on-demand streaming service. The platform offers access to a vast library of over 14 million songs and one million albums, available across multiple devices including mobile apps for iPhone and Android, web browsers, and various streaming devices. MOG's user-friendly interface, exceptional discovery features, and high audio quality set it apart from competitors. Additionally, MOG operates The MOG Music Network, which is a prominent online destination for music content and the largest music-focused advertising network, attracting over 60 million unique visitors each month across more than 1,500 music websites. Headquartered in Berkeley, California, MOG has received investment from notable firms, including Menlo Ventures and Universal Music Group, and features Grammy-winning producer Rick Rubin on its Board of Directors.

Sonoma Orthopedics

Series B in 2007
Sonoma Orthopedic Products specializes in the design, development, and delivery of proprietary orthopedic implants aimed at assisting physicians in the treatment of problematic fractures. The company's innovative WaviBody technology platform facilitates quick and minimally invasive surgical solutions, catering to the needs of active patients. By focusing on advanced orthopedic solutions, Sonoma Orthopedic Products aims to enhance patient recovery and overall quality of care.

Catalist Homes

Series D in 2007
Catalist Homes is a real estate company providing a higher quality of client service through professional personnel working out of local offices and backed with tremendous corporate support. A reduction in fees would be meaningless if your home did not achieve its maximum value on the market. The good news for CataList Home's clients is they not only save thousands of dollars in fees, but yield higher prices and almost identical marketing times than other homes sold in the market. Data from hundreds of CataList sales in Los Angeles and Orange County prove that they achieve the highest sold price to listing price The truth is, it does not cost any real estate agent more than 3% to sell a home. Fees in excess of 3% represent an excessive charge to the home seller for the use of a real estate agent involved in an old, inefficient and costly system. Instead, you should be asking: "How can Realtors continue to charge five and six percent commissions (typically eliminating 20-25% of homeowner equity) when the average home is sold in less than 30 days?" When you consider the fact that home prices have virtually doubled in the last five years, how can Realtors keep the commission percentage the same and essentially double their fee? Your conventional agent is asking you for a 100% pay raise in 5 years, and he wants you to pay for it. A 3% commission in 2006 is the same dollar cost as 6% just five years ago when you factor in home appreciation. This is how they offer all the essential service for 3%.

Sonoma Orthopedics

Series A in 2007
Sonoma Orthopedic Products specializes in the design, development, and delivery of proprietary orthopedic implants aimed at assisting physicians in the treatment of problematic fractures. The company's innovative WaviBody technology platform facilitates quick and minimally invasive surgical solutions, catering to the needs of active patients. By focusing on advanced orthopedic solutions, Sonoma Orthopedic Products aims to enhance patient recovery and overall quality of care.

Mobile Content Networks

Series A in 2006
MCN (Mobile Content Networks) provides mobile search management and revenue solutions that connect mobile users directly to the content they seek while delivering profitable new revenue streams for operators and content providers. MCN is led by an experienced, global management team and backed by some of the most successful venture capital firms in the U.S. and Japan. Before launching the company in 2004, MCN conducted a multi-year study of the unique characteristics of the mobile commerce ecosystem. Equipped with a thorough understanding of the industry’s unique needs, MCN pioneered real-time federated search management, as well as the mobile industry’s highest performing paid search program, allwords.

Qumu

Series B in 2006
Qumu Corporation specializes in providing comprehensive tools for the creation, management, security, distribution, and delivery of live and on-demand video content tailored for enterprises. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services to enhance user experience. Its offerings cater to various sectors, including banking, finance, insurance, manufacturing, technology, healthcare, and government, through both direct sales and partnerships. Established in 1978 and headquartered in Minneapolis, Minnesota, Qumu was previously known as Rimage Corporation before rebranding in 2013.

MOG

Series A in 2006
MOG Inc. is a music media company founded in June 2005, focused on enhancing the music listening experience through its on-demand streaming service. The platform offers access to a vast library of over 14 million songs and one million albums, available across multiple devices including mobile apps for iPhone and Android, web browsers, and various streaming devices. MOG's user-friendly interface, exceptional discovery features, and high audio quality set it apart from competitors. Additionally, MOG operates The MOG Music Network, which is a prominent online destination for music content and the largest music-focused advertising network, attracting over 60 million unique visitors each month across more than 1,500 music websites. Headquartered in Berkeley, California, MOG has received investment from notable firms, including Menlo Ventures and Universal Music Group, and features Grammy-winning producer Rick Rubin on its Board of Directors.

Modviz

Seed Round in 2004
Modviz is a company that specializes in data visualization through its Virtual Graphics Platform. It offers software solutions designed to assist organizations in visualizing large 3D data sets on computing clusters. Additionally, Modviz provides a 3D graphics computing platform that facilitates data visualization and supports the development of custom OpenGL applications. This combination of tools enables users to effectively interpret complex data in a three-dimensional environment.

Clairvoyante, Inc.

Series B in 2004
Clairvoyante develops PenTile RGBW technology to optimize screen brightness, resolution, and power consumption of flat-panel liquid crystal displays that enables high-brightness and low-power displays that needs to support data-centric 3G applications and contents. Clairvoyante is a U.S.-based company that was founded in 2000 by Candice Brown Elliott. The company was acquired by Samsung Electronics on March, 2008.

NeoGuide

Series B in 2003
NeoGuide Systems Inc. is a developer of robotic endoscopic technology specifically designed for natural orifice transluminal endoscopic surgery (NOTES). Founded in 2000 and based in San Jose, California, the company focuses on creating advanced solutions for medical procedures, particularly in colonoscopy applications. Its innovative technology aims to enhance the visualization and delivery of therapies within the body, thereby improving access to abdominal and thoracic cavities. NeoGuide is positioned at the forefront of a transformative approach in minimally invasive surgery, contributing to the evolution of medical practices in the field.

Media Publisher

Series A in 2003
Media Publisher, Inc. (MPI) is the leader in Enterprise Video Communication, enabling Fortune 2000 companies to UNIFY content from a wide array of content providers and file types, CREATE live and on-demand video presentations, MANAGE video assets in a scalable and robust EVC platform, and DELIVER video content to an organization's existing network and computing infrastructure. Media Publisher Solutions offer significant value to the enterprise in Corporate Communications, Sales and Channel Enablement, and Engineering/R&D Distance Learning. Many large-scale, international customers have adopted Media Publisher Solutions to drive significant revenue generation benefits across the enterprise. Additionally, Media Publisher leverages past infrasturucture investments to deliver dramatic efficiency-gain and productivity benefits. Business video delivered via the internet is now a reliable and cost-effective communications tool for the enterprise. Corporate networks, video software applications, and enterprise infrastructure have matured to allow companies to broadcast streaming video presentations cost-effectively and easily without expensive proprietary hardware or satellite networks. Far more compelling than audio or web conferences, broadcast video helps companies communicate more effectively, improve productivity, and cut costs. Media Publisher enterprise software eliminates much of the technical complexity involved in creating, broadcasting and managing business video. Their products help large organizations remove IT as a process bottleneck while allowing IT to maintain control of their infrastructure and enabling even non-technical employees to fully utilize business video publishing and management tools. Enterprise-class and fully deployed and tested in eight of the Fortune 50, Media Publisher 4.0 is helping companies make broadcast video communications over IP a mission critical application.

Qumu

Series A in 2003
Qumu Corporation specializes in providing comprehensive tools for the creation, management, security, distribution, and delivery of live and on-demand video content tailored for enterprises. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services to enhance user experience. Its offerings cater to various sectors, including banking, finance, insurance, manufacturing, technology, healthcare, and government, through both direct sales and partnerships. Established in 1978 and headquartered in Minneapolis, Minnesota, Qumu was previously known as Rimage Corporation before rebranding in 2013.

AirPrime

Series B in 2000
The company develops code division multiple access chipsets for wireless voice and data products.

YY Technologies

Venture Round in 2000
YY is the world leader in Natural Language Processing technology, offering software that enables computers to really understand language as people naturally speak or write it. This means that YY software understands: - Full sentences, not just keywords and menu choices - Multiple sentences and multiple topics in the same message - Sentences with incorrect grammar, structure, spelling or punctuation - Either text or voice input YY software translates natural language sentences and paragraphs to detailed XML instructions, thus enabling written or spoken natural language to be the interface to a variety of database and other applications. With YY, automatic machine-generated responses are 99% accurate the first time, are generated within 60 seconds of the input, and include order processing information, embedded links to relevant documents, and other data relevant to responding to the user's need.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.